Search Results - "HA, Chul S"

US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL by Ravandi, Farhad, Othus, Megan, O'Brien, Susan M., Forman, Stephen J., Ha, Chul S., Wong, Jeffrey Y.C., Tallman, Martin S., Paietta, Elisabeth, Racevskis, Janis, Uy, Geoffrey L., Horowitz, Mary, Takebe, Naoko, Little, Richard, Borate, Uma, Kebriaei, Partow, Kingsbury, Laura, Kantarjian, Hagop M., Radich, Jerald P., Erba, Harry P., Appelbaum, Frederick R.

“…This multicenter trial was conducted to determine whether the addition of dasatinib to chemotherapy followed by an allogeneic hematopoietic cell transplant…”
Get full text

Commissioning an Elekta Versa HD linear accelerator by Narayanasamy, Ganesh, Saenz, Daniel, Cruz, Wilbert, Ha, Chul S., Papanikolaou, Niko, Stathakis, Sotirios

“…The purpose of this study is to report the dosimetric aspects of commissioning performed on an Elekta Versa HD linear accelerator (linac) with high‐dose‐rate…”
Get full text

Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens by Swanson, Gregory P., Epstein, Jonathan I., Ha, Chul S., Kryvenko, Oleksandr N.

“…Background Surveillance and focal therapy are increasingly considered for low risk prostate cancer (PC). We describe pathological characteristics of low risk…”
Get full text

p53-Based Strategy for Protection of Bone Marrow From Y-90 Ibritumomab Tiuxetan by Su, Hang, PhD, Ganapathy, Suthakar, PhD, Li, Xiaolei, PhD, Yuan, Zhi-Min, MD, PhD, Ha, Chul S., MD

“…Purpose The main drawbacks of radioimmunotherapy have been severe hematological toxicity and potential development of myelodysplastic syndrome and secondary…”
Get full text

Evaluation of Dosimetry Check software for IMRT patient‐specific quality assurance by Narayanasamy, Ganesh, Zalman, Travis, Ha, Chul S., Papanikolaou, Niko, Stathakis, Sotirios

“…The purpose of this study is to evaluate the use of the Dosimetry Check system for patient‐specific IMRT QA. Typical QA methods measure the dose in an array…”
Get full text

The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis by Jensen, Garrett L., Jhavar, Sameer G., Ha, Chul S, Hammonds, Kendall P., Swanson, Gregory P.

“…•Pelvic nodal radiation to 54 Gy correlates with worse urinary quality of life.•Pelvic nodal radiation to 45 Gy does not correlate with urinary quality of…”
Get full text

Image-guided radiation therapy in lymphoma management by Eng, Tony, Ha, Chul S

“…Image-guided radiation therapy (IGRT) is a process of incorporating imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI),…”
Get full text

Clinical course of solitary extramedullary plasmacytoma by Liebross, Robert H, Ha, Chul S, Cox, James D, Weber, Donna, Delasalle, Kay, Alexanian, Raymond

“…Background and purpose: Solitary extramedullary plasmacytoma (EMP) represents a rare category of malignant disease on which there are limited data in regard to…”
Get full text

Long-Term Follow-Up of a Prospective Study of Combined Modality Therapy for Stage I–II Indolent Non-Hodgkin’s Lymphoma by SEYMOUR, John F, PRO, Barbara, HESS, Mark, COX, James D, CABANILLAS, Fernando, MCLAUGHLIN, Peter, FULLER, Lillian M, MANNING, John T, HAGEMEISTER, Fredrick B, ROMAGUERA, Jorge, RODRIGUEZ, Maria A, HA, Chul S, SMITH, Terry L, AYALA, Ana

“…Standard therapy for patients with stage I-II indolent lymphoma has been involved-field radiation therapy (IF-XRT), which achieves 10-year disease-free…”
Get full text

ACR Appropriateness Criteria Follow-up of Hodgkin Lymphoma by Ha, Chul S., MD, Hodgson, David C., MD, Advani, Ranjana, MD, Dabaja, Bouthaina S., MD, Dhakal, Sughosh, MD, Flowers, Christopher R., MD, MS, Hoppe, Bradford S., MD, MPH, Mendenhall, Nancy P., MD, Metzger, Monika L., MD, Plastaras, John P., MD, PhD, Roberts, Kenneth B., MD, Shapiro, Ronald, MD, Smith, Sonali, MD, Terezakis, Stephanie A., MD, Winkfield, Karen M., MD, PhD, Younes, Anas, MD, Constine, Louis S., MD

“…The main objectives of follow-up studies after completion of treatment for Hodgkin lymphoma are detection of recurrence for salvage therapy and monitoring for…”
Get full text

Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy by Chronowski, Gregory M., Ha, Chul S., Wilder, Richard B., Cabanillas, Fernando, Manning, John, Cox, James D.

“…BACKGROUND Although surgery is considered standard therapy for unicentric Castleman disease, favorable responses to radiotherapy also have been documented. The…”
Get full text

Image-guided radiation therapy in lymphoma management by Eng, Tony, Ha, Chul S

“…Image-guided radiation therapy (IGRT) is a process of incorporating imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI),…”
Get full text

Multiple myeloma of the cervical spine : treatment strategies for pain and spinal instability by RAO, Ganesh, HA, Chul S, CHAKRABARTI, Indro, FEIZ-ERFAN, Iman, MENDEL, Ehud, RHINES, Laurence D

“…Metastases of multiple myeloma often occur in the cervical spine. These metastases may cause pain and associated spinal instability. The authors report the…”
Get full text

Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy by Liebross, R H, Ha, C S, Cox, J D, Weber, D, Delasalle, K, Alexanian, R

“…To clarify the natural history of solitary plasmacytoma of bone (SBP) after radiation treatment. Between 1965-1996, we identified 57 previously untreated…”
Get more information

A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma by Fang, Penny, Gunther, Jillian R., Pinnix, Chelsea C., Dong, Wenli, Strati, Paolo, Nastoupil, Loretta J., Steiner, Raphael E., Ahmed, Sairah, Damron, Ethan P., Fowler, Nathan, Nair, Ranjit, Westin, Jason R., Neelapu, Sattva, Ha, Chul S., Dabaja, Bouthaina S.

“…We report the long-term results of a prospective trial conducted to determine the efficacy and safety of radiation therapy (RT) alone in treating localized…”
Get full text

Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone by Wilder, Richard B., Ha, Chul S., Cox, James D., Weber, Donna, Delasalle, Kay, Alexanian, Raymond

“…BACKGROUND Prognostic factors for solitary plasmacytoma of bone (SPB), whether measured before or after radiotherapy (RT), have not been established. The…”
Get full text

Primary Mediastinal B Cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium Society Appropriate Use Criteria by Hoppe, Bradford S., Advani, Ranjana, Milgrom, Sarah A., Bakst, Richard L., Ballas, Leslie K., Dabaja, Bouthaina S., Flowers, Christopher R., Ha, Chul S., Mansur, David B., Metzger, Monika L., Pinnix, Chelsea C., Plastaras, John P., Roberts, Kenneth B., Smith, Sonali M., Terezakis, Stephanie A., Kirwan, Jessica M., Constine, Louis S.

“…Primary mediastinal B cell lymphoma (PMBCL) is a highly curable subtype of non-Hodgkin lymphoma that is diagnosed predominantly in adolescents and young…”
Get full text

Imexon Augments Sensitivity of Human Lymphoma Cells to Ionizing Radiation: In Vitro Experimental Study by Cho, Heunglae, Koto, Masashi, Riesterer, Oliver, Molkentine, David P, Giri, Uma, Milas, Luka, Story, Michael D, Ha, Chul S, Raju, Uma

“…Background: Imexon is an aziridine-containing small pro-oxidant molecule with promising antitumor activity in myeloma, lymphoma and lung and pancreatic cancer…”
Get full text

International prognostic index‐based outcomes for diffuse large B‐cell lymphomas by Wilder, Richard B., Rodriguez, Maria A., Medeiros, L. Jeffrey, Tucker, Susan L., Ha, Chul S., Romaguera, Jorge E., Pro, Barbara, Hess, Mark A., Cabanillas, Fernando, Cox, James D.

“…BACKGROUND We present the results of doxorubicin‐based chemotherapy with or without involved‐field radiotherapy for patients with diffuse large B‐cell lymphoma…”
Get full text

Clinical Outcomes of Spatially Fractionated GRID Radiotherapy in the Treatment of Bulky Tumors of the Head and Neck by Choi, J Isabelle, Daniels, Janeen, Cohen, Dane, Li, Ying, Ha, Chul S, Eng, Tony Y

“…Objectives The clinical outcomes of patients treated with spatially fractionated GRID radiotherapy (SFGRT) for bulky tumors of the head and neck at a single…”
Get full text